DiscoverBuilding the FutureIn 20 years cell and gene therapies for cancer will be commonplace
In 20 years cell and gene therapies for cancer will be commonplace

In 20 years cell and gene therapies for cancer will be commonplace

Update: 2021-09-06
Share

Description

Cancer is one of the world’s most devastating diseases. Its treatment can be punishing, and have several nasty side effects. Fortunately, scientists have a better idea now of how to treat it, and the experimental techniques being used now may be commonplace in the future. At least, that’s what many experts think.

Host Rudy van Beurden has invited three guests who are experts in this field: Jacqueline Barry, Chief Clinical Officer at CT Catapult; Erik Manting, CEO at Immunicum AB and Trudy Straetemans, Assistant Professor at UMC Utrecht.

Do you want to learn more about these speakers or this podcast? Check out kadans.com/podcast.kadans, cancer, cell therapy, gene therapy, disease, experimental

Building the Future is brought to you by Kadans Science Partner.
Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

In 20 years cell and gene therapies for cancer will be commonplace

In 20 years cell and gene therapies for cancer will be commonplace

Kadans Science Partner